Company profiles

Print

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15.0 billion in 66 countries.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Sanofi Genzyme
500 Kendall Street,
Cambridge, MA 02142
USA
VP Media Relations
Contact person: Erin Pascal
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families. Learn more at http://www.sanofigenzyme.com/
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis Group companies employ approximately 122,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world.
Boston Scientific (NYSE: BSX) is a worldwide developer, manufacturer and marketer of medical devices with approximately 27,000 employees and revenue of $8.4 billion in 2016.
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit http://www.bostonscientific.eu/ and connect on Twitter (@bostonsci) and Facebook.
Teva is among the top 15 global pharmaceutical companies, delivering high-quality, patient-centric healthcare solutions used by approximately 200 million patients in 60 markets every day. Diseases of the central nervous system represent a key therapeutic area for Teva, with the company producing a world leading multiple sclerosis (MS) therapy. In neurology, Teva is dedicated to providing treatments for migraine and headache, movement disorders, neurodegenerative conditions and pain, and has late-stage development programs in a number of these neurological conditions. In Europe, Teva operates a number of research & development facilities, production and distribution centres, with the company’s European headquarters based in Amsterdam, the Netherlands



At US WorldMeds our mission is to market meaningful products that improve lives and result in a thriving community of patients. We hold a fundamental belief that our science has the potential to improve the lives of Parkinson’s patients. US WorldMeds’ commitment to Parkinson’s patients is reflected in all that we do. Our pipeline of development projects, along with our two currently available PD treatments, reflects our resolve to bring innovative solutions to Parkinson’s patients.

Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics. For more information, please visit www.biogen.com.

CeGaT GmbH
Paul-Ehrlich-Str. 23
72076 Tuebingen, Germany
Email:
info@cegat.de
Website: http://www.cegat.de/
CeGaT is a leading global provider of genetic diagnostics and mutation-related disease analyses. The company combines its next-generation sequencing (NGS) process and analysis pipelines with its medical expertise - dedicated to identifying the genetic cause of disease and supporting patient management.
Genetic mutations can trigger a wide range of diseases, from epilepsy to Parkinson’s. Through the use of NGS, it is possible to analyze all genes associated with a disease phenotype simultaneously – both fast and effectively. An interdisciplinary team of scientists and human geneticists evaluates the data and summarizes the findings in a comprehensive medical report. All services are performed in-house. CeGaT, founded in 2009 and based in Tübingen, Germany, is accredited according to CAP, CLIA and DIN EN ISO 15189:2014. The company provides human genetics services worldwide.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. We meet patients’ need using the latest technologies to develop and deliver innovative biotherapies that are used to treat serious and rare conditions such as coagulation disorders, primary immune deficiencies, hereditary angioedema and inherited respiratory disease.


UNIPHARM HOLDINGS Sp. z o. o.
ul. Puławska 428, 02-884 Warszawa
Tel: 22 855 00 66-67; Fax: 22 643 81 60
NIP 9512441769; REGON: 367822108
Website: http://www.unipharm.pl/
Email: info@unipharm.pl



UNIPHARM is an American pharmaceutical company headquartered in Empire State Building in New York with 15 branch offices worldwide. For over 25 years the Company has specialized in the development and marketing of over-the-counter drugs and nutritional products. UNIPHARM brands are leaders in the categories focused on patients and physicians needs in prevention and treatment of lifestyle diseases. UNIPHARM provides innovative solutions inter alia in neurology, rheumatology, orthopedy, endocrinology, ophthalmology.

UNIPHARM is first to market with unique nutraceutical AXOBREX, which provides inner salt of citicoline, a new neuroplastic and neuroprotective opportunity in therapeutic area of neurology and ophthalmology.

Edra Urban & Partner Sp. z o.o.
ul. Kościuszki 29; 50-011 Wrocław,
Telephone: (+48 71) 330 61 89
Fax: (+48 71)330 61 60
Edra Urban & Partner, the new Polish reality in healthcare and part of Edra LSWR, the leading Italian provider of innovative solutions for the health system, acquires publishing activities of Elsevier Urban & Partner, the most authoritative and recognized medical publisher in Poland. Over twenty years of experience and a catalog boasting more than 800 titles have made Elsevier Urban & Partner the first point of reference for students and professionals in Poland.
Edra Urban & Partner intends to create comprehensive offers for the Polish health and medical environment, which will result in customers having access to more diverse and richer content with innovative products and services.


We are a pharmaceutical company based in Elizówka near Lublin. We operate in the market since 2005. Thanks to our long experience and dynamic development we are one of the fastest growing companies in the pharmaceutical industry in the Lubelskie province.
We create unique solutions for keeping good health, offering a vast choice of: foods for special medical purposes, medical devices, medicinal products, dietary supplements, cosmetic products.
We do our best to adjust not only to the changing requirements of the market, but also to the customers’ expectations. While constantly incorporating new products into our offer, we rely on researching the patients’ needs, as well as on the opinions of people from the medical community. We won the doctors’, pharmacists’ and patients’ trust, for we use the latest production technologies, as well as pay utmost attention to providing the best quality.

Wisepress Medical Bookshop
25 High Path, Merton Abbey,
London, SW19 2JL UK
Telephone: +44 20 8715 1812
Fax: +44 20 8715 1722
Email: marketing@wisepress.com,
Website: http://www.wisepress.com/
Wisepress.com, Europe's leading conference bookseller, has a range of books and journals relevant to the themes of the meeting. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers. Follow us on Twitter for the latest news @WisepressBooks.

POLISH STROKE SOCIETY has been established in 2002 in Bydgoszcz to hold and support activities for the stroke therapy, prevention and education. As an interdisciplinary scientific society, it gathers almost 300 specialists, including neurologists, cardiologist, neurosurgeons and rehabilitation specialists, focused on stroke therapy, prevention and rehabilitation. Annually, POLISH STROKE SOCIETY organises interdisciplinary stroke meetings or congress dedicated to specific stroke aspects. In the wide field of activities, POLISH STROKE SOCIETY cooperates with Polish Society for Emergency Medicine, Section of Neurosonology of Polish Neurological Society, Danube Teaching Courses and numerous Polish and international experts.